hemagglutinin/saratani

Kiungo kimehifadhiwa kwenye clipboard

Chagua aina ya aina

7 matokeo

Viruses lacking epithelial cell receptor entry

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

BACKGROUND 1. Technical Field This document provides methods and materials related to viruses and the treatment of diseases such as cancer. 2. Background Information Measles virus (MV) is one of the most contagious human pathogens. It is transmitted by aerosols, infecting a new host via the upper

Viruses lacking epithelial cell receptor entry

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Cell surface protein and effector cell bonding reagent

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

This is a national phase filing of the application No. PCT/EP95/00843, which was filed with the Patent Corporation Treaty on Mar. 7, 1995, and is entitled to priority of the German Patent Application P 44 07 538.3, filed Mar. 7, 1994. I. FIELD OF THE INVENTION The present invention relates to a

Methods of identifying a compound that increases or decreases the interaction of Hn-33 with synaptotagmin II

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The invention relates to a biologically active hemagglutinin protein from the Clostridium botulinum type A neurotoxin complex and interacting host proteins. BACKGROUND Botulinum neurotoxins (BoNTs) are extremely potent proteins with a mouse lethal dose of 0.3 ng/kg. Seven

Alpha-selective sialyl phosphate donors for preparation of sialosides and sialoside arrays for influenza virus detection

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

TECHNICAL FIELD OF THE INVENTION The invention generally relates to the synthesis of sialosides. In particular, the invention relates to synthesis of disialides using novel sialyl phosphate donor compounds. Specifically, the invention relates to synthesis of polysialic acids using novel sialyl

Noninvasive genetic immunization, expression products therefrom and uses thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

FIELD OF THE INVENTION The present invention relates generally to the fields of immunology and vaccine technology. The present invention also relates to techniques of skin-targeted non-invasive gene delivery to elicit immune responses and uses thereof. The invention further relates to methods of

Noninvasive genetic immunization, expression products therefrom, and uses thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala

Ingia / Ingia

Jiunge na ukurasa
wetu wa facebook

Herbal & Natural Medicine

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

Inafanya kazi katika lugha 55
Uponyaji wa mitishamba unaungwa mkono na sayansi
Kutambua mimea kwa picha
Ramani ya GPS inayoshirikiana
Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
Tafuta mimea ya dawa na athari zao
Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa